The company offers a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source, enabling clients to enhance clinical trial workflows, reduce manual labor, and have access to data anytime. Clinical Ink's solutions include Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements. Their goal is to drive the industry standard for data precision and usher in a new generation of clinical trials by harnessing digital data to power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.